Boehringer backs AI-powered anti-infective startup ArrePath
pharmaphorum
MARCH 7, 2022
The Princeton, New Jersey-based startup will use the funding to develop its artificial intelligence and imaging based drug discovery platform, used to identify compounds with new and under-exploited mechanisms of action. million deaths a year, according to the 2019 Gram Report. Dr Zemer Gitai.
Let's personalize your content